About Teikoku Seiyaku
About
News
-
- 2025.12.19
- Announcement of Sales Partnership Agreement in Japan for New Osteoarthritis Treatment Agent
-
- 2025.6.11
- Promotion of joint educational activities on knee osteoarthritis
-
- 2025.3.27
- Change in The Board of Directors
-
- 2023.6.29
- President and CEO Misako Fujioka Interviewed in Newsweek International
-
- 2023.3.28
- Change in The Board of Directors
Company
Since our foundation over 170 years ago, Teikoku Seiyaku has used the transdermal technology we have cultivated to respond to and anticipate the needs of both patients and medical professionals.
View More














